Clinical trial
A Prospective, Multicenter Survey of Cytomegalovirus (CMV) and Other Herpesviruses Infections and Diseases in Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT) Recipients.
NCT04412811 is registered in ClinicalTrials.gov with Gruppo Italiano Trapianto di Midollo Osseo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicenter Survey of Cytomegalovirus (CMV) and Other Herpesviruses Infections and Diseases in Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT) Recipients.
- Lead sponsor
- Gruppo Italiano Trapianto di Midollo Osseo
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2021
- Completion date
- March 31, 2023
- Enrollment
- 1,310 (actual)
- Sites
- 50
Conditions
As the registry lists them; a condition with its own page is linked.
cytomegalovirus viremia, hematologic diseases, herpesvirus infection, stem cell transplant complications